中华核医学杂志
中華覈醫學雜誌
중화핵의학잡지
CHINESE JOURNAL OF NUCLEAR MEDICINE
2009年
4期
227-229
,共3页
李凤岐%李现军%王健%赵志华%代学之%刘世娟%冯志徐
李鳳岐%李現軍%王健%趙誌華%代學之%劉世娟%馮誌徐
리봉기%리현군%왕건%조지화%대학지%류세연%풍지서
心肌梗塞%干细胞%移植%体层摄影术,发射型计算机,单光子%MIBI
心肌梗塞%榦細胞%移植%體層攝影術,髮射型計算機,單光子%MIBI
심기경새%간세포%이식%체층섭영술,발사형계산궤,단광자%MIBI
Myocardial infarction%Stem cells%Transplantation%Tomography,emission-computed,single-photon%MIBI
目的 用99Tcm-甲氧基异丁基异腈(MIBI)静息门控心肌灌注显像的方法 ,评价急性心肌梗死(AMI)患者自体骨髓间质干细胞(MSC)移植术治疗的疗效.方法 AMI患者31例,均行经皮冠状动脉介入治疗(PCl)术,其中18例患者作为试验组,于PCI术后行自体MSC移植术治疗,PCI术后拒绝行细胞移植治疗的13例患者作为对照组.于PCI术前,术后1,3和6个月进行99Tcm-MIBI静息门控心肌灌注断层显像,评价心肌血流灌注及心功能改善程度.统计学处理采用SPSS 11.0软件,行t检验.结果 所有患者术后1个月放射性稀疏节段数明显减少,术后3个月和6个月放射性缺损节段数试验组(2.37±1.09和2.21±0.93)较对照组(3.24±0.93和3.21±1.05)明显减少(t=2.32,2.79,P均<0.05);与术前[(35.4±16.7)%和(32.8±15.9)%]相比,术后6个月试验组[(57.2±14.3)%]和对照组[(44.8±11.7)%]患者左心室射血分数(LVEF)均显著升高(t=4.27,2.18,P均<0.05),试验组患者LVEF明显高于对照组(t=2.58,P<0.05).结论 心肌梗死患者自体MSC移植术后,应用99Tcm-MIBI静息门控心肌灌注显像随访和评价疗效有一定临床价值.
目的 用99Tcm-甲氧基異丁基異腈(MIBI)靜息門控心肌灌註顯像的方法 ,評價急性心肌梗死(AMI)患者自體骨髓間質榦細胞(MSC)移植術治療的療效.方法 AMI患者31例,均行經皮冠狀動脈介入治療(PCl)術,其中18例患者作為試驗組,于PCI術後行自體MSC移植術治療,PCI術後拒絕行細胞移植治療的13例患者作為對照組.于PCI術前,術後1,3和6箇月進行99Tcm-MIBI靜息門控心肌灌註斷層顯像,評價心肌血流灌註及心功能改善程度.統計學處理採用SPSS 11.0軟件,行t檢驗.結果 所有患者術後1箇月放射性稀疏節段數明顯減少,術後3箇月和6箇月放射性缺損節段數試驗組(2.37±1.09和2.21±0.93)較對照組(3.24±0.93和3.21±1.05)明顯減少(t=2.32,2.79,P均<0.05);與術前[(35.4±16.7)%和(32.8±15.9)%]相比,術後6箇月試驗組[(57.2±14.3)%]和對照組[(44.8±11.7)%]患者左心室射血分數(LVEF)均顯著升高(t=4.27,2.18,P均<0.05),試驗組患者LVEF明顯高于對照組(t=2.58,P<0.05).結論 心肌梗死患者自體MSC移植術後,應用99Tcm-MIBI靜息門控心肌灌註顯像隨訪和評價療效有一定臨床價值.
목적 용99Tcm-갑양기이정기이정(MIBI)정식문공심기관주현상적방법 ,평개급성심기경사(AMI)환자자체골수간질간세포(MSC)이식술치료적료효.방법 AMI환자31례,균행경피관상동맥개입치료(PCl)술,기중18례환자작위시험조,우PCI술후행자체MSC이식술치료,PCI술후거절행세포이식치료적13례환자작위대조조.우PCI술전,술후1,3화6개월진행99Tcm-MIBI정식문공심기관주단층현상,평개심기혈류관주급심공능개선정도.통계학처리채용SPSS 11.0연건,행t검험.결과 소유환자술후1개월방사성희소절단수명현감소,술후3개월화6개월방사성결손절단수시험조(2.37±1.09화2.21±0.93)교대조조(3.24±0.93화3.21±1.05)명현감소(t=2.32,2.79,P균<0.05);여술전[(35.4±16.7)%화(32.8±15.9)%]상비,술후6개월시험조[(57.2±14.3)%]화대조조[(44.8±11.7)%]환자좌심실사혈분수(LVEF)균현저승고(t=4.27,2.18,P균<0.05),시험조환자LVEF명현고우대조조(t=2.58,P<0.05).결론 심기경사환자자체MSC이식술후,응용99Tcm-MIBI정식문공심기관주현상수방화평개료효유일정림상개치.
Objective Myocardial cell regeneration therapy is one of the most researched topics in modern medical science. The objective of this study was to evaluate the clinical value of 99Tcm-methoxyisobutylisonitrile (MIBI) rest gated myocardial perfusion imaging in patients with acute myocardial infarction (AMI) treated by stem cell transplantation. Methods Thirty-one patients with AMI were all treated by percutaneous coronary intervention (PCI). And 18 of them subsequently had mesenchymal stem cell (MSC) transplantation therapy. All the patients were examined by 99Tcm-MIBI rest gated myocardial perfusion imaging at the time before and after PCI to evaluate the left ventricular myocardial perfusion and function. The t-test was used to compare data statistically with SPSS 11.0. Results The number of myocardial segments with perfusion abnormalities decreased in all the AMI patients 1 month after PCI. The number of myocardial segments with perfusion defects decreased 3 to 6 months after PCI in the patients treated by MSC transplantation (2.37±1.09 and 2.21±0.93 ) when compared with the control group without MSC transplantation therapy (3.24±0.93 and 3.21±1.05, t =2.32,2.79, both P <0.05).The left ventricular ejection fraction (LVEF) of the patients treated by MSC transplantation increased 6 months after PCI compared with the control group [(57.2±14.3) % and (44.8±11.7) %, respectively, t=2.58, P<0.05]. Condusion 99Tcm-MIBI rest gated myocardial perfusion imaging is an effective functional imaging to evaluate the therapeutic response in patients with AMI treated by MSC transplantation.